Filter
1039
Filtered Results: 1039
Text search:
World
Health
Organization
WHO,
Western
Pacific
Region
Featured
Recommendations
101
New Publications
247
Language
Document type
No document type
484
Studies & Reports
285
Guidelines
135
Manuals
47
Strategic & Response Plan
42
Fact sheets
11
Training Material
10
Situation Updates
9
Resource Platforms
9
Infographics
6
Online Courses
1
Countries / Regions
Global
95
Philippines
37
Western Pacific Region
28
South–East Asia Region
27
India
20
Nepal
19
Asia
19
Africa
18
Cambodia
18
Western and Central Europe
17
Myanmar / Burma
17
Kenya
12
Latin America and the Carribbean
11
Bangladesh
11
Russia
8
China
7
Syria
7
Nigeria
7
South Africa
7
Ethiopia
7
Indonesia
7
Liberia
7
Afghanistan
6
Eastern Europe and Central Asia
6
Papua New Guinea
6
Thailand
5
Ukraine
5
Sierra Leone
5
Tanzania
5
Middle East and North Africa
5
Eastern Europe
5
Pakistan
5
Rwanda
4
Malawi
4
Congo, Democratic Republic of
4
West and Central Africa
4
East and Southern Africa
4
Yemen
4
South Sudan
4
Somalia
4
Ghana
3
Mozambique
3
Fiji
2
Laos
2
Senegal
2
Zimbabwe
2
Mongolia
2
Guinea
2
USA
2
Haiti
2
Venezuela
2
Vietnam
2
Sri Lanka
2
Zambia
2
Madagascar
2
North Korea
1
Colombia
1
Timor Leste/ East Timor
1
Mexico
1
Serbia
1
Benin
1
Cameroon
1
Iran
1
Burkina Faso
1
Vanuatu
1
Jordan
1
Japan
1
Uganda
1
Moldova
1
Namibia
1
Egypt
1
Sudan
1
Palestine
1
Central African Republic
1
Bhutan
1
Botswana
1
Iraq
1
Ecuador
1
Solomon Islands
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
201
Clinical Guidelines
130
Public Health
85
Women & Child Health
70
Key Resources
60
Capacity Building
16
Pharmacy & Technologies
14
Toolboxes
HIV
112
Mental Health
100
COVID-19
74
Planetary Health
66
Rapid Response
51
TB
48
NTDs
47
Global Health Education
42
AMR
37
Disability
35
Caregiver
32
NCDs
25
Pharmacy
24
Refugee
20
Natural Hazards
19
Conflict
15
Zika
14
Health Financing Toolbox
11
Ebola & Marburg
9
Polio
8
Cholera
4
Specific Hazards
3
Malaria
2
Typhoon
2
Social Ethics
1
The report focuses on antibacterial resistance (ABR) in common bacterial pathogens. There is a major gap in knowledge about the magnitude of this problem. Antimicrobial resistance (AMR) threatens the effective revention and treatment of an ever-increasing range of infections caused by bacteria, para...
Results of rapid assessment
The COVID-19 pandemic has disrupted or halted critical mental health services in 93% of countries worldwide while the demand for mental health is increasing, according to a new WHO survey. The survey of 130 countries provides the first global data showing the devastating...
This report on global leishmaniasis surveillance follows those published in 2016–2023.2–6 Six indicators of leishmaniasis are publicly available from the Global Health Observatory (GHO).7 In addition to the GHO, country profiles with up to 30 indicators are published, with detailed data received...
Dengue is a mosquito-borne viral disease that has rapidly spread to all regions of WHO in recent years. Dengue virus is transmitted by female mosquitoes mainly of the species Aedes aegypti and, to a lesser extent, Ae. albopictus. These mosquitoes are also vectors of chikungunya, yellow fever and Zik...
The World Health Organization provides regional and national strategies and operational plans that aim to support countries in work to achieve measles control and elimination. These are guided by high level frameworks including the Immunization Agenda 2030 and the Measles and Rubella Strategic Frame...
Road safety is an issue that does not receive anywhere near the attention it deserves – and it really is one
of our great opportunities to save lives around the world
The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens.
However, these products are in the very early stages of development and still need to be proven effective and safe. The optimistic scenario, the report indicates, is for...
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
Weekly epidemiological update on COVID-19, 28 September 2022
Report of a global meeting on yaws eradication surveillance, monitoring and evaluation: Geneva, 29–30 January 2018. World Health Organization.
Bulletin of the World Health Organization 2016. doi: http://dx.doi.org/10.2471/BLT.16.171082
Objective: To describe the temporal and geographical distribution of Zika virus infection, and associated neurological disorders, from 1947 to February 2016.
Practical actions in cities to strengthen preparedness for the COVID-19 pandemic and beyond
recommended
This document accompanies the interim guidance on “Strengthening Preparedness for COVID-19 in cities and urban settings”. It provides local authorities, leaders and policy-makers in cities with a checklist tool to ensure that key areas have been covered. An excel version that local authorities m...
As of October 2017, the global database comprised almost 30 000 records, including results from bioassays to measure phenotypic resistance, and biochemical and molecular tests for resistance mechanisms. The current report presents an overview of data on malaria vector resistance for 2010 to 2016. It...
